The outline should be drawn a little larger than the area of visible hyperpigmentation
Hegele b Purpose of review Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are becoming more prominent as a therapeutic choice in diabetes management and their use is being expanded to other indications, such as obesity
Our analysis included a total of 81,738 patients, of which 73,033 (89.4%) had pre-existing cardiovascular disease or were at high risk of ASCVD
If you are transitioning your care to Japan, you will need to consult with a local specialist (usually a gastroenterologist or an internal medicine physician)
Typically, they are temporary and disappear after the person stops taking the medication
The required labeling for some GLP-1 receptor agonists indicated for glycemic control in patients with type 2 diabetes include warnings and precautions regarding acute gallbladder disease in the U.S